Syndax Pharmaceuticals, Inc. (SNDX): Price and Financial Metrics
Syndax Pharmaceuticals, Inc. (SNDX)
Today's Latest Price: $22.87 USD
Updated Nov 27 1:00pm
Add SNDX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
SNDX Stock Summary
- Syndax Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 9.45% of US listed stocks.
- SNDX's price/sales ratio is 623.55; that's higher than the P/S ratio of 99.03% of US stocks.
- With a year-over-year growth in debt of 1,948.95%, Syndax Pharmaceuticals Inc's debt growth rate surpasses 98.81% of about US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Syndax Pharmaceuticals Inc are OTIC, KLDO, CKPT, QURE, and DCPH.
- SNDX's SEC filings can be seen here. And to visit Syndax Pharmaceuticals Inc's official web site, go to www.syndax.com.
SNDX Stock Price Chart Interactive Chart >
SNDX Price/Volume Stats
| Current price | $22.87 | 52-week high | $23.98 |
| Prev. close | $23.13 | 52-week low | $6.32 |
| Day low | $22.57 | Volume | 658,842 |
| Day high | $23.40 | Avg. volume | 516,841 |
| 50-day MA | $17.95 | Dividend yield | N/A |
| 200-day MA | $15.12 | Market Cap | 934.67M |
Syndax Pharmaceuticals, Inc. (SNDX) Company Bio
Syndax Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics in oncology. The company was founded in 2005 and is based in Waltham, Massachusetts.
Loading social stream, please wait...